Cannabis Science Releases its 2017 Guidance Report for 2nd Quarter 2017, and Outlines Company's Performance and Growth Opportunities as the Medical Cannabis Industry Expands Dramatically

Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has already achieved a good number of its goals for 2017. Cannabis Science is aggressively expanding its corporate footprint in legal states throughout the USA, to help self-medicating patients with multiple critical ailments.

Marapharm Ventures Inc. 'Marapharm' Announces a Private Placement of up to 80 Million Share Purchase Warrants

Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) announces the proposed offering of up to 80 million share purchase warrants. Each warrant will be offered for a consideration of 10 cents (CDN) per warrant for a total of gross proceeds of up to $8 million dollars and are exercisable into one common share for the price of $2.90 per share for a period of 3 years from the date of closing (the "warrants"). 

Cannabis is More Effective at Treating Migraine Pain than Prescription Drugs

New research shows that cannabis can not only treat migraines and cluster headaches, but do so more effectively compared to conventional treatment. Participants in the study suffered from either chronic migraines or cluster headaches. Migraines cause all-over headache pain and nausea as well as a sensitivity to light and sound. Cluster headaches typically cause pain in one area, usually within proximity to the eyes. Researchers needed to determine the actual dosage they would use in the study.

Inaugural Index Highlights Monthly Demand in Marijuana Industry

As marijuana continues to receive recognition from the business industry itching for a new market to break into, no one has consistently measured the actual demand for marijuana state-by-state.

That is, no one has until now: last week, the Anderson Economic Group (AEG) released its inaugural AndCan Index, billed as the “Dow Jones Industrial Average for the Cannabis Market.”

Q&A: Nevada to Launch Legal Pot Sales on Saturday

Lines are expected Saturday outside some medical marijuana dispensaries in Las Vegas and other Nevada cities that will begin selling pot for recreational use for the first time since voters approved it in November.

It’s the fastest turnaround from the ballot box to retail sales of any of the seven other states and the District of Columbia where pot is legal.